Pediatric bone and soft tissue sarcomas, including osteosarcoma, Ewing sarcoma, and rhabdomyosarcoma, represent devastating ...

Emory University physician-sponsored clinical trial conducted at the Aflac Cancer and Blood Disorders Center at Children’s Healthcare of ...

Osteosarcoma is the most prevalent primary malignant bone tumor in children and adolescents. The current standard treatment ...

Indo–Italian experts from India, Italy, Malaysia, and Singapore convened in Bengaluru for the Indo–Italian Consensus Meet on Sarcoma and Complex Orthopaedic Reconstruction, held on December 5th & ...

St. Jude Children's Research Hospital scientists have identified a promising combination approach to treat a rare but ...

Actuate Therapeutics, Inc. has announced the completion of the Phase 1 study evaluating its drug elraglusib in pediatric patients with refractory malignancies, specifically Ewing Sarcoma (EWS). The ...

Bengaluru: Global experts from India, Italy, Malaysia and Singapore convened in Bengaluru for the Indo–Italian Consensus Meet ...

Osteosarcoma and Ewing sarcoma are bone cancers that primarily affect children, teens, and young adults. Symptoms they share include bone pain, stiffness, and swelling at the tumor site. About 2% of ...

The completion of multiple national pediatric precision oncology platform trials and the incorporation of standardized molecular profiling into the diagnostic care of pediatric and young adult ...

CHICAGO and FORT WORTH, Texas, July 17, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on ...

When 8-year-old Abram was diagnosed with Ewing sarcoma in his thigh, his family’s world shifted overnight. The news marked the start of a journey that would test their strength and endurance, while ...